Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular

Sefanja Achterberg1, Maarten J M Cramer, L Jaap Kappelle

  • 1Department of Neurology, Rudolf Magnus Institute of Neuroscience, Utrecht, The Netherlands.

Insights

Patients with cerebrovascular disease (CVD) or peripheral arterial obstructive disease (PAOD) face nearly double the risk of future vascular events compared to those with coronary artery disease (CAD). This highlights significant differences in vascular event risk among atherosclerosis subtypes.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Epidemiology

Background:

  • Atherosclerosis is a primary cause of coronary artery disease (CAD), cerebrovascular disease (CVD), and peripheral arterial obstructive disease (PAOD).
  • Patients with these conditions face a high risk of recurrent vascular events and mortality.
  • Direct comparative data on vascular event rates across these atherosclerosis manifestations are limited.

Purpose of the Study:

  • To directly compare vascular event rates and risk factors among patients with CAD, CVD, and PAOD.
  • To identify differences in risk profiles and outcomes between these distinct atherosclerotic diseases.

Main Methods:

  • A cohort of 3563 patients with nondisabling CAD, CVD, or PAOD was analyzed.
  • Regression analyses, adjusted for age and sex, were used to compare risk factors and outcomes over a median follow-up of 3.9 years.
  • Cox regression analysis compared the risk of the primary composite outcome (myocardial infarction, stroke, vascular death) across the three groups.

Main Results:

  • Vascular event rates averaged 2.5% annually.
  • Patients with CVD or PAOD had a significantly higher risk of major vascular events compared to CAD patients (Hazard Ratio [HR] for CVD/CAD: 1.7; PAOD/CAD: 1.8).
  • PAOD patients exhibited increased risk for coronary events, while CVD and PAOD patients had a higher risk for major bleeding compared to CAD patients.

Conclusions:

  • Patients recently diagnosed with CVD or PAOD face a nearly twofold increased risk of subsequent vascular events compared to those with CAD.
  • These findings underscore the differential prognosis associated with various manifestations of atherosclerosis.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...